Yamana, Teresa K.
Rajagopal, Swetha
Hall, Donald C. Jr.
Moustafa, Ahmed M.
Feder, Andries
Ahmed, Azad
Bianco, Colleen
Harris, Rebecca
Coffin, Susan
Campbell, Amy E.
Pei, Sen
Mell, Joshua Chang
Planet, Paul J.
Shaman, Jeffrey
Funding for this research was provided by:
Centers for Disease Control and Prevention (75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232, 75D30121C11102/000HCVL1-2021-55232)
Article History
Received: 25 January 2024
Accepted: 28 August 2024
First Online: 9 September 2024
Declarations
:
: All experimental protocols were approved by the Children’s Hospital of Pennsylvania IRB (IRB 21-018726). The study did not require direct interaction with human subjects and only involved review of medical records, with appropriate protections for storage and destruction of data. The IRB concluded that the study was minimal risk and was performed on specimens solely collected for non-research purposes that would have been discarded. Therefore, the CHOP IRB granted a waiver of consent. All data transmitted to outside institutions was completely deidentified and approved by the CHOP IRB.
: n/a.
: JLS and Columbia University disclose partial ownership of SK Analytics. JLS discloses consulting for BNI. The other authors declare no competing interests.